Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
  • Mar 09, 2026

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

  • Associated Press
Anti-obesity treatment could cost as little as $3 per month
  • Mar 09, 2026

Anti-obesity treatment could cost as little as $3 per month

  • Canadian Affairs
Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices
  •  —
  • Mar 08, 2026

Canada-U.S. Trade Minister and federal Health Minister meet with pharma sector as Trump doubles down on cutting U.S. drug prices

  • The Hill Times
  • Mar 07, 2026

Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract

  • CISION
Weight-loss jab could be made for $3 a month, study finds
  • Mar 06, 2026

Weight-loss jab could be made for $3 a month, study finds

  • The Guardian
U.S. FDA approves J&J's blood cancer drug after speedy review
  • Mar 06, 2026

U.S. FDA approves J&J's blood cancer drug after speedy review

  • Reuters
China approves pfizer's glp-1 drug for weight management
  • Mar 06, 2026

China approves pfizer's glp-1 drug for weight management

  • Reuters
AI brain fry: How ChatGPT, Claude overuse could impact your health
  •  —
  • Mar 06, 2026

AI brain fry: How ChatGPT, Claude overuse could impact your health

  • Axios
Amazon launches AI enabled platform in the U.S. to automate healthcare administrative tasks
  • Mar 05, 2026

Amazon launches AI enabled platform in the U.S. to automate healthcare administrative tasks

  • Reuters
Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds
  • Mar 04, 2026

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

  • The Guardian
Health-tech startup targets hospital procurement inefficiencies
  • Mar 04, 2026

Health-tech startup targets hospital procurement inefficiencies
3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
  • Mar 04, 2026

3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits

  • CBC News
New Glasgow, N.S., hospital getting AI-powered weapons detection system
  • Mar 04, 2026

New Glasgow, N.S., hospital getting AI-powered weapons detection system

  • CTV News
US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs
  • Mar 03, 2026

US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs

  • Reuters
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
  • Mar 03, 2026

3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests

  • CTV News
Danielle Smith calls on Ottawa to deregulate sales of nicotine pouches
  • Mar 02, 2026

Danielle Smith calls on Ottawa to deregulate sales of nicotine pouches

  • Times Colonist
Artificial intelligence could reduce emergency room mental health visits at CHEO
  •  —
  • Mar 02, 2026

Artificial intelligence could reduce emergency room mental health visits at CHEO

  • Ottawa Citizen
Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes
  • Mar 02, 2026

Health Canada approves Ozempic to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes

  • CISION
Group calls on Health Canada to make labels mandatory for gene-edited pork
  • Mar 01, 2026

Group calls on Health Canada to make labels mandatory for gene-edited pork

  • CTV News
AI minister says OpenAI still not doing enough in wake of B.C. shooting, will meet CEO Altman
  • Feb 27, 2026

AI minister says OpenAI still not doing enough in wake of B.C. shooting, will meet CEO Altman

  • CBC News
European regulators recommend approval of combined mRNA vaccine for flu and COVID
  • Feb 27, 2026

European regulators recommend approval of combined mRNA vaccine for flu and COVID

  • CIDRAP
FDA to offer bonus payments to staffers who complete speedy drug reviews
  • Feb 27, 2026

FDA to offer bonus payments to staffers who complete speedy drug reviews

  • Associated Press
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion
  • Feb 26, 2026

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

  • Reuters
Novavax raises revenue forecast on boost from vaccine deals, shares soar
  • Feb 26, 2026

Novavax raises revenue forecast on boost from vaccine deals, shares soar

  • Reuters
AI-powered weapons screening system comes to Cape Breton Regional Hospital
  •  —
  • Feb 26, 2026

AI-powered weapons screening system comes to Cape Breton Regional Hospital

  • Saltwire
B.C. teen first in world to be cured of rare disease through gene editing treatment
  • Feb 26, 2026

B.C. teen first in world to be cured of rare disease through gene editing treatment

  • Vancouver Sun
Study to examine whether Ozempic can reduce the risk of blood cancer
  •  —
  • Feb 26, 2026

Study to examine whether Ozempic can reduce the risk of blood cancer

  • The Globe and Mail
New GLP-1 pill helped trial patients lose up to 8% of body weight
  • Feb 26, 2026

New GLP-1 pill helped trial patients lose up to 8% of body weight

  • The Guardian
Dozens of Ontario nursing homes competed for a spot in culture-change pilot project
  • Feb 25, 2026

Dozens of Ontario nursing homes competed for a spot in culture-change pilot project

  • Toronto Star
Lethbridge County pens deal for virtual health care with Rocket Doctor
  • Feb 25, 2026

Lethbridge County pens deal for virtual health care with Rocket Doctor

  • CTV News
No 'substantial' new safety measures offered by OpenAI following Tumbler Ridge shooting, says minister
  • Feb 25, 2026

No 'substantial' new safety measures offered by OpenAI following Tumbler Ridge shooting, says minister

  • Toronto Star
FDA says a plausible mechanism can be enough for rare disease approval : NPR
  • Feb 23, 2026

FDA says a plausible mechanism can be enough for rare disease approval : NPR
Grail's Cancer Detection Test Fails in Major Study
  •  —
  • Feb 23, 2026

Grail's Cancer Detection Test Fails in Major Study

  • The New York Times
Decline in remote jobs risks shutting disabled people out of work, study finds
  • Feb 22, 2026

Decline in remote jobs risks shutting disabled people out of work, study finds

  • The Guardian
  • Feb 21, 2026

The Health Minister said much last week

  • CHW Insights
  •  — 
  • Nick Tsergas
Grail shares plummet after UK study raises doubts over cancer test's prospects
  • Feb 20, 2026

Grail shares plummet after UK study raises doubts over cancer test's prospects

  • Reuters
Could saliva tests become the future of diagnosis?
  • Feb 20, 2026

Could saliva tests become the future of diagnosis?
BioNTech sues Moderna for patent infringement over COVID-19 shots
  • Feb 19, 2026

BioNTech sues Moderna for patent infringement over COVID-19 shots

  • CTV News
FDA chief says 'everything should be over the counter' unless drug is unsafe or addictive
  • Feb 19, 2026

FDA chief says 'everything should be over the counter' unless drug is unsafe or addictive

  • CNBC
FDA will drop two-study requirement for new drug approvals
  • Feb 19, 2026

FDA will drop two-study requirement for new drug approvals

  • Associated Press
Big Pharma financially unfazed by Trump drug price deals
  • Feb 19, 2026

Big Pharma financially unfazed by Trump drug price deals

  • Axios
I took part in a 2012 psilocybin trial. What I'm seeing now horrifies me
  • Feb 19, 2026

I took part in a 2012 psilocybin trial. What I'm seeing now horrifies me

  • STAT

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing